Skip to main content
Fig. 5 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 5

From: Role of 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography in assessment of neoadjuvant chemotherapy response in breast cancer patients

Fig. 5

56 years old female patient with history of right breast cancer submitted for MRM followed by chemotherapy presented with left breast cancer (invasive ductal carcinoma, luminal B subtype). Axial CECT and fused PET/CT images (a, b) revealed metabolically active left breast soft tissue mass lesion achieving 3 SULpeak. On follow-up after completion of chemotherapy, stationary appearance of the left breast mass regarding size and FDG uptake is noted in both axial CECT and fused PET/CT images (c, d) denoting stationary disease and stationary metabolic disease

Back to article page